Tango Therapeutics, Inc.
TNGXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $4.19B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.69$34.39
- Volume (live)
- -
- Avg. volume (3M)
- 3.69M
Tango Therapeutics (TNGX) Stock Price & Financial Analysis
Tango Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $25.94 - $27.98 |
|---|---|
| 52-Week High | $34.39 |
| 52-Week Low | $6.69 |
| Open | $26.67 |
| Volume (last close) | 5.96M |
| Average Volume (3M) | 3.69M |
| Revenue (TTM) | 53.81M |
|---|---|
| Net Income (TTM) | -123.72M |
| Free Cash Flow (TTM) | -144.27M |
| EPS (TTM) | −$0.94 |
| Profit Margin | -229.92% |
| Operating Margin | -253.38% |
| Return on Equity (ROE) | -12.08% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.19B |
|---|---|
| Shares Outstanding | 149.88M |
| Price to Sales (P/S) | 77.79 |
| Price to Book (P/B) | 4.09 |
| EV/EBITDA | -30.23 |
| 50-Day MA | $23.84 |
|---|---|
| 200-Day MA | $21.81 |
| 1-Year Change | +270.92% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Tango Therapeutics at a Glance
As of the Oct 22, 2026 close, Tango Therapeutics (TNGX) has a market capitalization of $4.19B. The stock trades at 77.8× sales. Over the trailing twelve months it lost $123.72M on revenue of $53.81M and burned $144.27M of free cash flow. Revenue grew 121.5% year over year.
As of its latest reported balance sheet, it holds $345.56M in cash and securities against $31.99M of debt, a net cash position of $313.57M.
Tango Therapeutics does not currently pay a dividend.
The share price is up 270.9% over the past year. At $27.93 (the Oct 22, 2026 close) it sits within its 52-week range of $6.69 to $34.39, above its 200-day moving average of $21.81.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $42.00, 50.4% above the Oct 22, 2026 close.
Frequently Asked Questions About Tango Therapeutics
What is the current stock price for TNGX?
As of the Oct 22, 2026 close, TNGX stock trades at $27.93. The 52-week range is $6.69–$34.39, with a day range of $25.94–$27.98.
What is the P/E ratio for TNGX?
The P/E ratio (Price-to-Earnings) for TNGX is shown in the Key Statistics section. This valuation metric helps compare Tango Therapeutics, Inc. to industry peers.
Does TNGX pay dividends?
Tango Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TNGX?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for TNGX is Buy. The average 12-month price target is $42.00, a 50.4% upside from the Oct 22, 2026 close of $27.93.
What is the market cap of TNGX?
As of the Oct 22, 2026 close, Tango Therapeutics's market capitalization is $4.19B, classifying it as a mid-cap company. Tango Therapeutics operates in the Healthcare sector within the Biotechnology industry.